TVRD · Forms 3, 4, 5
Insider trades at Tvardi Therapeutics, Inc.
No open-market insider buys or sells at Tvardi Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Tvardi Therapeutics, Inc. (TVRD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Tvardi Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Susan Ph.D. Shiff | Director | Options or other derivatives | Form 4 | ||||
| Cynthia Smith | Director | Options or other derivatives | Form 4 | ||||
| Sujal Shah | Director | Options or other derivatives | Form 4 | ||||
| Wallace L Hall Jr | Director | Options or other derivatives | Form 4 | ||||
| Michael S Wyzga | Director | Options or other derivatives | Form 4 | ||||
| Stephen Paul O'Brien | Principal Accounting Officer | Options or other derivatives | Form 4 | ||||
| Avi Daniel Conn | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| John Saewook M.D. Kauh | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Imran Nizamudin Alibhai | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Stephen Paul O'Brien | Principal Accounting Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.